Home |
Search |
Today's Posts |
#1
|
|||
|
|||
The shares should easliy be worth $100+ within a year....
The shares should easliy be worth $100+ within a year.
Anthrax, AIDs, Cancer, Baldness Cures...when will it soar? Well if any of us knew the future, we'd all be billionaires now instead of later. However, one can take an educated guess that Avanir (AVN) is poised to become the single most important investment of our lifetimes. Anyone who has followed this company knows for sure that every Wall Street shark try to put them out of business to take over the lucrative Xenerex patents they hold. These patents employ the same technology which Avanir used to perfect the anthrax mAB with near 100% positive results. Now Avanir has a multi-billion dollar drug up for FDA priority approval with an 84% improvement rate in MS patients. The CEO has cleverly put a poison pill in place to stop any hostile takeover attemtps by the Wall Street sharks, thus allowing AVN to move forward with their plans of raking in billions in profits from Neurodex and using those profits to fund the Xenerex project. If Avanir can replicate their success in attacking defective genes in man with the same results that they have gotten with their anthrax mAB, they will well be on their way to becoming the single most important and cutting edge company in existence. We are talking about AIDs, cancer, baldness cures and cures to just about any other genetic defect in man using the information provided from genome mapping and employing Avanir's very unique and patented Xenerex antibody technology. Yes, I'm betting it will soar (and that's an understatement). Even if I could forecast the future and knew exactly when it will soar, I wouldn't tell you. I'm loading up with as many shares as I can afford now while the foolish shorts have created an ideal situtation for longs to accumulate at ridiculously low prices. This is a move that they will regret for the rest of their lives. Insider Buying / * AVN CEO Aquires 2M Shares*~ This is extremely BULLISH ~~~STRONG BUY~~~ YAKATAN, GERALD J.: Declared Holdings Company/Relationship Reported Shares Ownership AVANIR PHARMACEUTICL Chief Executive Officer AMEX:AVN 2,000,000 AVN Acquisition (Non Open Market) at $2.65 per share.(Value of $5,300,000) Also, biotech guru, Jonathan Silverstein recently did a private purchase of 900,000 shares bring him in control of 8,775,000 shares. Avanir Pharmaceuticals, symbol AVN, Potential multi-billion dollar blockbuster drug in Phase 3 with remarkable results up for FDA Priority Approval, fantastic Anthrax Antibody, unique CancerCompound unlike anything ever seen before, IgE for allergies andasthma, Abreva herpes cream worldwide, unique Stem Cell patent, anti- cholestoral drug,MIF tech, Xenerex subsidiary for the production of the only completely human mABs. ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ ~~~~~~~~~~~~~~~~~~~~~ $100+ Within a Yr., Shares Are Scarce The shorts are in trouble and have created a false illusion of the pps. Shares are scarce and that is why the bashers and naysayers are are on the boards. It's plain and simple. They are not there 24/7 because they don't like to sleep, eat regularly or ever have sex. There is alot of money at stake for those wanting to steal your valuable AVN shares and those that have been foolishly short and increasing their invisible, floating, short position for 5 years now in a desperate attempt to scare out the retail owners of this gem. They are in deep ****. The shares should easily be worth $100+ within a year. Avanir Reports Anti-Anthrax Findings Data presented at the 105th General Meeting of the American Society for Microbiology (ASM) described activity of AVANIR Pharmaceuticals' (AMEX:AVN - News) fully human monoclonal antibody treatment against inhalation anthrax. The data demonstrates that one dose (lowest dose tested was 1 mg/kg) of AVANIR's antibody, AVP 21D9, completely protected rabbits challenged with 100xLD50 dose of B. anthracis administered nasally. All animals, re-challenged three weeks later with anthrax but without additional antibody treatment, survived re-challenge as well. The data also showed that AVP 21D9 worked synergistically with the antibiotic Ciprofloxacin to protect mice and guinea pigs. Anthrax, AIDS, Cancer, Baldness Cures...when will it soar? Well if any of us knew the future, we'd all be billionaires now instead of later. However, one can take an educated guess that Avanir (AVN) http://www.avanir.com is poised to become the single most important investment of our lifetimes and $100+ is a conservative estimate of where it's heading short-term. Anyone who has followed this company knows for sure that every Wall Street shark tried to put them out of business to take over the lucrative Xenerex patents they hold. These patents employ the same technology which Avanir used to perfect the anthrax mAB with near 100% positive results. Now Avanir has a multi-billion dollar drug up for FDA priority approval with an 84% improvement rate in MS patients. The former CEO cleverly put a poison pill in place to stop any hostile takeover attemtps by the Wall Street sharks, thus allowing AVN to move forward with their plans of raking in billions in profits from Neurodex and using those profits to fund the Xenerex project. If Avanir can replicate their success in attacking defective genes inherit to man with the same results that they have gotten with their anthrax mAB, they will well be on their way to becoming the single most important and cutting edge company in existence. We are talking about AIDS, cancer, baldness cures and cures to just about any other genetic defect inherit to man using the information provided from genome mapping and employing Avanir's very unique and patented Xenerex antibody technology. Yes, I'm betting it will soar (and that's an understatement). Even if I could forecast the future and knew exactly when it will soar, I wouldn't tell you. I'm loading up with as many shares as I can afford now while the foolish shorts have created an ideal situtation for longs to accumulate at ridiculously low prices. This is a move that they will regret for the rest of their lives. http://www.avanir.com http://www.xenerex.com Insider Buying / * former AVN CEO Aquires 2M Shares*~ This is extremely BULLISH ~~~STRONG BUY~~~ YAKATAN, GERALD J.: Declared Holdings Company/Relationship Reported Shares Ownership AVANIR PHARMACEUTICL Chief Executive Officer AMEX:AVN 2,000,000 AVN Acquisition (Non Open Market) at $2.65 per share.(Value of $5,300,000) Also, biotech guru, Jonathan Silverstein recently did a private purchase of 900,000 shares bring him in control of 8,775,000 shares. Avanir Pharmaceuticals, symbol AVN, Potential multi-billion dollar blockbuster drug in Phase 3 with remarkable results up for FDA Priority Approval, fantastic Anthrax Antibody, unique CancerCompound unlike anything ever seen before, IgE for allergies andasthma, Abreva herpes cream worldwide, unique Stem Cell patent, anti- cholestoral drug,MIF tech, Xenerex subsidiary for the production of the only completely human mABs. For more info... http://www.avanir.com http://www.xenerex.com ..,. |
Thread Tools | Search this Thread |
Display Modes | |
|
|
Similar Threads | ||||
Thread | Forum | |||
78 Seastar - Engine Block Cracked (Ice) - Worth Rebuilding? | General | |||
Is this worth restoring? | Boat Building |